CN112028944A - Organic iridium complex containing heteroatom, preparation method thereof and photoelectric device - Google Patents

Organic iridium complex containing heteroatom, preparation method thereof and photoelectric device Download PDF

Info

Publication number
CN112028944A
CN112028944A CN202010929227.XA CN202010929227A CN112028944A CN 112028944 A CN112028944 A CN 112028944A CN 202010929227 A CN202010929227 A CN 202010929227A CN 112028944 A CN112028944 A CN 112028944A
Authority
CN
China
Prior art keywords
formula
formulae
iridium complex
unsubstituted
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010929227.XA
Other languages
Chinese (zh)
Inventor
王辉
李小龙
孙峰
邱镇
汪康
曹淼
马晓宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olide Shanghai Photoelectric Material Technology Co ltd
Original Assignee
Olide Shanghai Photoelectric Material Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olide Shanghai Photoelectric Material Technology Co ltd filed Critical Olide Shanghai Photoelectric Material Technology Co ltd
Priority to CN202010929227.XA priority Critical patent/CN112028944A/en
Publication of CN112028944A publication Critical patent/CN112028944A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0033Iridium compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/342Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The invention discloses an organic iridium complex containing heteroatoms, a preparation method thereof and a photoelectric device, belonging to the field of organic photoelectric materials, wherein the structural general formula of the organic iridium complex is as follows:
Figure DDA0002669605920000011
in the formula, R1、R2Represents at least one or no substituent, R3、R4、R5Represents a single or no substituent; r1、R2The substituent position is any position of the ring on which each is positioned; a is any one of C3-C10 naphthenic base and C3-C12 heterocyclic radical; b is any one of C3-C10 naphthenic base, C3-C12 heterocyclic radical and C6-C20 aryl; and the condition that the ring of A is isoquinoline and the ring of B is a benzene ring does not exist simultaneouslyThe method is described. According to the invention, the specific heterocyclic ligand combination is selected, the wavelength of the compound is adjusted, and the obtained organic iridium complex can improve the current efficiency and the service life of the device after being used for an organic electroluminescent device.

Description

Organic iridium complex containing heteroatom, preparation method thereof and photoelectric device
Technical Field
The invention relates to the field of organic photoelectric materials, in particular to an organic iridium complex containing heteroatoms, a preparation method thereof and a photoelectric device.
Background
Organic electroluminescence was discovered as early as the beginning of the 20 th century. The Pope et al, the university of New Yo rk, 1963, first reported electroluminescent devices of single-crystal anthracene, but the driving power industry was too high and the thickness was too thick to receive attention. Until 1987, Tang et al of kodak corporation in the united states, using Alq as a light emitting layer, has attracted great interest from scientists in various countries after a low voltage and high brightness device is obtained, and has become a research focus in the international world in the last decade, and the organic light emitting device has been developed rapidly.
The Organic Light Emitting Device (OLED) is composed of a cathode, an anode and organic layers inserted between the cathode and the anode, namely the device is composed of a transparent ITO anode, a hole injection layer (ETL), a Hole Transport Layer (HTL), a light Emitting Layer (EL), a Hole Blocking Layer (HBL), an Electron Transport Layer (ETL), an Electron Injection Layer (EIL) and the cathode, and 1-2 organic layers can be omitted as required. The OLED has the action mechanism that voltage is formed between two electrodes, electrons are injected from a cathode on one side, holes are injected from an anode on the other side, the electrons and the holes are recombined in a light-emitting layer to form an excited state, the excited state returns to a stable ground state, and the device emits light.
And the light emitting material of the organic light emitting diode is mainly a phosphorescent light emitting material. The independent light emission of three primary colors of red, blue and green is the most adopted color mode at present, and the technical key point is to improve the color purity and efficiency of the luminescent material. Therefore, in recent years, research into organic phosphorescent materials has been conducted, and the most of them is a metal iridium complex.
As the light emitting material, excitons are formed by recombination of electrons and holes injected from each electrode. Singlet excitons emit fluorescence and triplet excitons emit phosphorescence. The singlet excitons emitted have a formation probability of 25%, while the triplet excitons emitting phosphorescence have a formation probability of 75%. Thus, triplet excitons provide greater current efficiency than singlet excitons. Among such phosphorescent materials, organic phosphorescent materials may have greater current efficiency than fluorescent materials. Therefore, organic phosphorescent materials are being widely studied as an important factor for improving the efficiency of organic electroluminescent devices.
However, the organic phosphor luminescent materials disclosed so far have certain disadvantages in current efficiency and life. Therefore, the development of a material with high current efficiency and long service life is a technical problem to be solved at present.
Disclosure of Invention
It is an object of embodiments of the present invention to provide a heteroatom-containing organic iridium complex to solve the problems set forth in the background art.
In order to achieve the above purpose, the embodiments of the present invention provide the following technical solutions:
a heteroatom-containing organic iridium complex has a general structural formula of formula I:
Figure BDA0002669605910000021
in the formula, R1、R2Represents at least one or no substituent, R3、R4、R5Represents a single or no substituent; r1、R2The substituent position is any position of the ring on which each is positioned;
R1、R2、R3、R4、R5each independently is hydrogen, deuterium atom, halogen, cyano, nitro, hydroxyl, amino, sulfonic group, sulfonyl, phosphoryl, substituted or unsubstituted alkyl of C1-C60, substituted or unsubstituted aryl of C6-C60, substituted or unsubstituted cycloalkyl of C3-C60, substituted or unsubstituted alkoxy of C1-C60, substituted or unsubstituted alkylamino of C1-C60, substituted or unsubstituted C2 to C60 alkylene, substituted or unsubstituted C2 to C60 alkynyl, substituted or unsubstituted C2 to C60 heterocyclic group, substituted or unsubstituted C10 to C60 condensed ring group;
a is any one of C3-C10 naphthenic base and C3-C12 heterocyclic radical; b is any one of C3-C10 naphthenic base, C3-C12 heterocyclic radical and C6-C20 aryl; and the condition that the ring of A is isoquinoline and the ring of B is a benzene ring does not exist at the same time.
Preferably, R1、R2、R3、R4、R5Each independently is at least one of hydrogen, deuterium atom, halogen, cyano, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C2-C20 heterocyclic group, substituted or unsubstituted C6-C20 aryl, and substituted or unsubstituted C10-C20 condensed ring group.
Preferably, in the formula, R3、R4、R5At least one of which is F.
Wherein the hydrogen atom in each of the above groups or substituents may be replaced by a deuterium atom.
Preferably, the organic iridium complex has the chemical formula I-1, formula I-2, formula I-3, formula I-4, formula I-5, formula I-6, formula I-7, formula I-8, formula I-9, formula I-10, formula I-11, formula I-12, formula I-13, formula I-14, formula I-15, formula I-16, formula I-17, formula I-18, formula I-19, formula I-20, formula I-21, formula I-22, formula I-23, formula I-24, formula I-25, formula I-26, formula I-27, formula I-28, formula I-29, formula I-30, formula I-31, formula I-32, formula I-33, formula I-34, Formula I-35, formula I-36, formula I-37, formula I-38, formula I-39, formula I-40, formula I-41, formula I-42, formula I-43, formula I-44, formula I-45, formula I-46, formula I-47, formula I-48, formula I-49, formula I-50, formula I-51, formula I-52, formula I-53, formula I-54, formula I-55, formula I-56, formula I-57, formula I-58, formula I-59, formula I-60, formula I-61, formula I-62, formula I-63, formula I-64, formula I-65, formula I-66, formula I-67, formula I-68, formula I-69, formula I-70, formula I-71, Formula I-72, formula I-73, formula I-74, formula I-75, formula I-76, formula I-77, formula I-78, formula I-79, formula I-80, formula I-81, formula I-82, formula I-83, formula I-84, formula I-85, formula I-86, formula I-87, formula I-88, formula I-89, formula I-90, formula I-91, formula I-92, formula I-93, formula I-94, formula I-95, formula I-96, formula I-97, formula I-98, formula I-99, formula I-100, formula I-101, formula I-102, formula I-103, formula I-104, formula I-105, formula I-106, formula I-107, formula I-108, formula I-95, Formula I-109, formula I-110, formula I-111, formula I-112, formula I-113, formula I-114, formula I-115, formula I-116, formula I-117, formula I-118, formula I-119, formula I-120, formula I-121, formula I-122, formula I-123, formula I-124, formula I-125, formula I-126, formula I-127, formula I-128, formula I-129, formula I-130, formula I-131, formula I-132, formula I-133, formula I-134, formula I-135, formula I-136, formula I-137, formula I-138, formula I-139, formula I-140, formula I-141, formula I-142, formula I-143, formula I-144, formula I-145, Any one of formulae I-146, formulae I-147, formulae I-148, formulae I-149, formulae I-150, formulae I-151, formulae I-152, formulae I-153, formulae I-154, formulae I-155, formulae I-156, formulae I-157, formulae I-158, formulae I-159, formulae I-160:
Figure BDA0002669605910000041
Figure BDA0002669605910000051
Figure BDA0002669605910000061
Figure BDA0002669605910000071
Figure BDA0002669605910000081
Figure BDA0002669605910000091
Figure BDA0002669605910000101
Figure BDA0002669605910000111
Figure BDA0002669605910000121
Figure BDA0002669605910000131
Figure BDA0002669605910000141
Figure BDA0002669605910000151
Figure BDA0002669605910000161
Figure BDA0002669605910000171
Figure BDA0002669605910000181
Figure BDA0002669605910000191
Figure BDA0002669605910000201
Figure BDA0002669605910000211
Figure BDA0002669605910000221
Figure BDA0002669605910000231
another object of an embodiment of the present invention is to provide a preparation method of the above organic iridium complex, which includes the following steps:
taking a compound with a structural general formula of formula II and a compound with a structural general formula of formula III;
reacting a compound with a general formula II with iridium trichloride to obtain a compound with a general formula IV;
reacting a compound with a general formula IV and a compound with a general formula III to obtain the organic iridium complex;
Figure BDA0002669605910000241
preferably, in the step, the compound with the general structural formula II and the iridium trichloride are reacted in a mixed solution of ethylene glycol ethyl ether and water.
Further, the mol ratio of the compound with the structural general formula of formula II to the iridium trichloride is (2.2-2.8): 1; in the mixed solution of the ethylene glycol ethyl ether and water, the volume ratio of the ethylene glycol ethyl ether to the water is 3: 1; the dosage of the mixed solution is 15-30 times of that of iridium trichloride; the reaction time is preferably 24 to 30 hours.
Preferably, in the step, the compound with the general structural formula IV and the compound with the general structural formula III are reacted in ethylene glycol ether containing alkali.
Further, the molar ratio of the compound with the structural general formula IV to the compound with the structural general formula III is 1 (2.5-8); the dosage of the ethylene glycol ethyl ether is 10-30 times of that of the compound with the structural general formula IV; the reaction time is 10 to 30 hours, preferably 20 to 24 hours.
Preferably, the base is anhydrous potassium carbonate or anhydrous sodium carbonate.
Another object of the embodiments of the present invention is to provide an application of the above organic iridium complex in the preparation of organic electroluminescent devices.
It is another object of an embodiment of the present invention to provide an optoelectronic device, including a first electrode, a second electrode, and at least one organic layer disposed between the first electrode and the second electrode, the organic layer including the above-mentioned organic iridium complex.
Preferably, the organic layer includes a light emitting layer; the light-emitting layer comprises a host material and a doping material; the doping material partially or entirely contains the organic iridium complex.
Preferably, the mass ratio of the host material to the doping material is (90-99.5): (0.5-10).
Specifically, the first electrode is an anode, the type of which is not particularly limited, and may be a conventional anode known to those skilled in the art, and more preferably is one of ITO (indium tin oxide), tin oxide, zinc oxide, and indium oxide, and the thickness of the first electrode is 10 to 500 nm. The second electrode is a cathode, the kind of which is not particularly limited, and is a conventional cathode known to those skilled in the art, and more preferably one of Al, Li, Na, K, Mg, Ca, Au, Ag, and Pb, and the thickness of the second electrode is 100 to 1000 nm.
The main material is preferably one or more of 4, 4'-N, N' -biphenyl dicarbazole (CBP), octahydroxyquinoline (Al q3), metal phenoxybenzothiazole compounds, polyfluorene, aromatic condensed rings and zinc complexes. The thickness of the light emitting layer is 10 to 500 nm.
In addition, the organic layer may further include other functional layers, and the other functional layers may be specifically selected from one or more of the following functional layers: a Hole Injection Layer (HIL), a Hole Transport Layer (HTL), a hole injection-hole transport functional layer (i.e., having both hole injection and hole transport functions), an Electron Blocking Layer (EBL), a Hole Blocking Layer (HBL), an Electron Transport Layer (ETL), an Electron Injection Layer (EIL), and an electron transport-electron injection functional layer (i.e., having both electron transport and electron injection functions).
The kind of each functional layer is not particularly limited, and may be a conventional functional layer known to those skilled in the art.
Preferably: the hole injection layer is one of 2-TNATA (namely N1- (2-naphthyl) -N4, N4-di (4- (2-naphthyl (phenyl) amino) phenyl) -N1-phenyl benzene-1, 4-diamine), phthalocyanine and porphyrin compounds, starburst triarylamine, a conductive polymer, an N-type semiconductive organic complex and a metal organic complex, and the thickness of the hole injection layer is 10-500 nm.
The hole transport layer is one of NPB (namely N, N '-diphenyl-N, N' - (1-naphthyl) -1, 1 '-biphenyl-4, 4' -diamine), TPD (namely N, N '-diphenyl-N, N' - (3-methylphenyl) -1, 1 '-biphenyl-4, 4' -diamine), PAPB (namely N, N '-bis (phenanthrene-9-yl) -N, N' -diphenyl benzidine) arylamine carbazole compound and indolocarbazole compound, and the thickness of the hole transport layer is 10-500 nm.
The hole blocking layer is one of BAlq, BCP and BPhen, and the thickness of the hole blocking layer is 10-500 nm.
The electron transport layer is one of Alq3, coumarin No. 6, triazole derivatives, azole derivatives, oxadiazole derivatives, imidazole derivatives, fluorenone derivatives and anthrone derivatives, and the thickness of the electron transport layer is 10-500 nm.
The electron injection layer is LiF, CsF or Li2O、Al2O3And MgO with a thickness of 0.1-10 nm.
In the embodiment of the present invention, the above light emitting layer and other various functional layers may be formed by a solution coating method and a vacuum deposition method. The solution coating method means spin coating, dip coating, inkjet printing, screen printing, spraying method, etc., but is not limited thereto.
The above-mentioned photoelectric device may be an organic electroluminescent device, an organic solar cell, electronic paper, an organic photoreceptor, an organic thin film transistor, or the like, but is not limited thereto.
Compared with the prior art, the embodiment of the invention has the beneficial effects that:
according to the organic iridium complex containing the heteroatom, the specific heterocyclic ligand combination is selected, the wavelength of the compound is adjusted, and the obtained organic iridium complex can remarkably improve the current efficiency of a photoelectric device and prolong the service life of the photoelectric device after being used for the photoelectric device such as an organic electroluminescent device. In addition, the preparation method of the organic iridium complex provided by the embodiment of the invention has the advantages of simple process and high purity of the prepared product, and can be applied to industrial production.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments.
Complex example 1
The embodiment of the complex provides an organic iridium complex containing hetero atoms, the chemical structural formula of the complex is shown as a formula I-4 in the summary of the invention, and the reaction route of the preparation method of the organic iridium complex is as follows:
Figure BDA0002669605910000271
the specific preparation method comprises the following steps:
(1) ligand II-4 (13.27g, 50mmol), IrC1, was weighed out under nitrogen protection3·3H2O (7.05g, 20mmo1) is put into a reaction system, a mixed solution of 330mL of ethylene glycol ethyl ether and 110mL of purified water is added, the mixture is refluxed for 25 hours under the protection of nitrogen, then cooled to room temperature, precipitates are separated out, the precipitates are filtered, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence to obtain dark red powderThe bridged ligand IV-4, having a mass of 8.17g, was present in a yield of 54%.
(2) Then weighing the bridging ligand IV-4 (7.56g, 5mmol), adding anhydrous potassium carbonate (6.9g, 50mmol), adding 150ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula III-4 (1.89g, 15mmol) under nitrogen, refluxing for 24 hours under the protection of nitrogen, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as a solvent, performing chromatography by using a neutral alumina column, concentrating the filtrate, and precipitating a solid to obtain the organic iridium complex shown in the formula I-4, wherein the mass of the organic iridium complex is 3.72g, the yield is 44%, and the HPLC purity is more than 99.5%.
In addition, the mass spectrum of the organic iridium complex is calculated as 846.03; the test value was 846.27.
The calculated value of the elemental analysis (%) > is C: 58.21; h is 5.24; f is 6.74; 22.72 parts of Ir; n is 3.31; o is 3.78; test value C is 58.23; h is 5.25; f is 6.75; 22.70 parts of Ir; n is 3.31; o is 3.76.
As can be seen by comparing the calculated values with the test values, the measured values are substantially consistent with the theoretical values, thereby proving that the organic iridium complex with the structural formula I-4 can be successfully synthesized by the complex example.
Complex example 2
The embodiment of the complex provides an organic iridium complex containing hetero atoms, the chemical structural formula of the complex is shown as the formula I-36 in the invention, and the reaction route of the preparation method of the organic iridium complex is as follows:
Figure BDA0002669605910000281
the specific preparation method comprises the following steps:
(1) ligand II-36 (14.60g, 46mmol), IrC1 was weighed out under nitrogen protection3·3H2O (7.05g, 20mmo1) is put into a reaction system, a mixed solution of 360mL of ethylene glycol ethyl ether and 120mL of purified water is added, the mixture is refluxed for 30 hours under the protection of nitrogen, then cooled to room temperature, precipitates are separated out, the precipitates are filtered, water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence, and bridge-linking powder of dark red powder is obtainedLigand IV-36, weight 10.96g, yield 64%.
(2) Then weighing the bridging ligand IV-36 (10.27g, 6mmol), adding anhydrous potassium carbonate (9.11g, 66mmol), adding 180ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula III-36 (4.97g, 20mmol) under nitrogen, refluxing for 22 hours under nitrogen protection, cooling, filtering, washing with alcohol, and drying. Dichloromethane and toluene are used as solvents, neutral alumina column chromatography is carried out, filtrate is concentrated and solid is separated out, and finally the organic iridium complex shown in the formula I-36 is obtained, the mass is 5.41g, the yield is 42%, and the HPLC purity is more than 99.5%.
In addition, the mass spectrum of the organic iridium complex is calculated as 1072.46; the test value was 1072.46.
The calculated value of the elemental analysis (%) > is C: 66.08; h is 6.86; f is 3.54; 17.92 parts of Ir; 2.61 of N; o is 2.98; test value C: 66.07; h is 6.84; f is 3.53; 17.94 parts of Ir; 2.63 of N; o is 2.98.
As can be seen by comparing the above calculated values with the test values, the measured values substantially agree with the theoretical values, thereby proving that the organic iridium complexes of the structural formulae I to 36 can be successfully synthesized by the above complex examples.
Complex example 3
The embodiment of the complex provides an organic iridium complex containing hetero atoms, the chemical structural formula of the complex is shown as a formula I-61 in the summary of the invention, and the reaction route of the preparation method of the organic iridium complex is as follows:
Figure BDA0002669605910000291
the specific preparation method comprises the following steps:
(1) ligand II-61 (13.89g, 48mmol), IrC1 was weighed out under nitrogen protection3·3H2O (7.05g, 20mmo1) is put into a reaction system, a mixed solution of 360mL of ethylene glycol ethyl ether and 120mL of purified water is added, the mixture is refluxed for 24 hours under the protection of nitrogen, then cooled to room temperature, precipitates are separated out, the precipitates are filtered, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence to obtain dark redThe bridging ligand IV-61 of the powder, having a mass of 9.81g, was found to be 61% yield.
(2) Then weighing the bridging ligand IV-61 (9.65g, 6mmol), adding anhydrous potassium carbonate (9.11g, 66mmol), adding 150ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula III-61 (6.74g, 18mmol) under nitrogen, refluxing for 20 hours under nitrogen protection, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as a solvent, performing chromatography by using a neutral alumina column, concentrating the filtrate, and precipitating a solid to obtain the organic iridium complex shown in the formula I-61, wherein the mass of the organic iridium complex is 5.89 g. The yield was 43% and the HPLC purity was greater than 99.5%.
In addition, the mass spectrum of the organic iridium complex is calculated as 1142.28; the test value was 1142.49.
The calculated value of the elemental analysis (%) > is C: 57.83; h is 5.12; f is 14.97; 16.83 parts of Ir; 2.45 of N; o is 2.80; test value C: 57.82; h is 5.10; f, 14.96; 16.83 parts of Ir; 2.47 of N; o is 2.82.
As can be seen by comparing the calculated values with the test values, the measured values are substantially consistent with the theoretical values, thereby proving that the organic iridium complexes with the structural formula I-61 can be successfully synthesized by the complex examples.
Complex example 4
The embodiment of the complex provides an organic iridium complex containing hetero atoms, the chemical structural formula of the complex is shown as the formula I-84 in the summary of the invention, and the reaction route of the preparation method of the organic iridium complex is as follows:
Figure BDA0002669605910000301
the specific preparation method comprises the following steps:
(1) ligand II-84 (12.73g, 44mmol), IrC1 were weighed out under nitrogen protection3·3H2O (7.05g, 20mmo1) is put into a reaction system, mixed solution of 420mL of ethylene glycol ethyl ether and 140mL of purified water is added, the mixture is refluxed for 24 hours under the protection of nitrogen, then cooled to room temperature, precipitates are separated out, the precipitates are filtered, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence to obtain darkThe red powder of bridged ligand IV-84 was 10.30g in mass, 64% yield.
(2) Then weighing the bridging ligand IV-84 (9.65g, 6mmol), adding anhydrous potassium carbonate (9.11g, 66mmol), adding 150ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula III-84 (3.78g, 18mmol) under nitrogen, refluxing for 20 hours under the protection of nitrogen, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as a solvent, performing chromatography by using a neutral alumina column, concentrating the filtrate, and precipitating a solid to obtain the organic iridium complex shown in the formula I-84, wherein the mass of the organic iridium complex is 6.10g, the yield is 52%, and the HPLC purity is more than 99.5%.
In addition, the mass spectrum of the organic iridium complex is calculated as 978.23; the test value was 978.56.
The calculated value of the elemental analysis (%) > is C: 62.62; h is 5.77; f is 5.83; 19.65 parts of Ir; 2.86 of N; o is 3.27; the test value is C: 62.60; h is 5.79; f is 5.84; 19.67 parts of Ir; 2.85 of N; o is 3.25.
As can be seen by comparing the above calculated values with the test values, the measured values substantially agree with the theoretical values, thereby proving that the organic iridium complexes of the formulae I to 84 can be successfully synthesized by the above complex examples.
Complex example 5
The embodiment of the complex provides an organic iridium complex containing hetero atoms, the chemical structural formula of the complex is shown as the formula I-95 in the invention, and the reaction route of the preparation method of the organic iridium complex is as follows:
Figure BDA0002669605910000311
the specific preparation method comprises the following steps:
(1) ligand II-95 (19.11g, 56mmol), IrC1, was weighed out under nitrogen protection3·3H2O (7.05g, 20mmo1) is put into a reaction system, mixed solution of 450mL of ethylene glycol ethyl ether and 150mL of purified water is added, reflux is carried out for 28 hours under the protection of nitrogen, then the mixture is cooled to room temperature, precipitates are separated out, the precipitates are filtered, and water, absolute ethyl alcohol and petroleum ether are used for washing and drying in sequence to obtain the productThe bridging ligand IV-95 was a dark red powder with a mass of 12.17g and a yield of 67%.
(2) Then weighing the bridging ligand IV-95 (11.81g, 6.5mmol), adding anhydrous potassium carbonate (8.97g, 65mmol), adding 200ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula III-95 (9.24g, 32.5mmol) under nitrogen, refluxing for 20 hours under the protection of nitrogen, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as a solvent, performing chromatography by using a neutral alumina column, concentrating the filtrate, and precipitating a solid to obtain the organic iridium complex shown in the formula I-95, wherein the mass of the organic iridium complex is 5.11g, the yield is 34%, and the HPLC purity is more than 99.5%.
In addition, the mass spectrum of the organic iridium complex is calculated as 1156.13; the test value was 1156.72.
Elemental analysis (%): calculated value is C57.14; h is 3.05; f is 13.15; 16.63 parts of Ir; n is 7.27; o is 2.77; test value C: 57.13; h is 3.04; f is 13.13; ir of 16.64; n is 7.28; o is 2.79.
As can be seen by comparing the calculated values with the test values, the measured values are substantially consistent with the theoretical values, thereby proving that the organic iridium complexes with the structural formula I-95 can be successfully synthesized by the complex examples.
Complex example 6
The embodiment of the complex provides an organic iridium complex containing hetero atoms, the chemical structural formula of the complex is shown as formula I-153 in the invention, and the reaction route of the preparation method of the organic iridium complex is as follows:
Figure BDA0002669605910000331
the specific preparation method comprises the following steps:
(1) weighing the formula II-153 (14.36g, 48mmol), IrC1 under the protection of nitrogen3·3H2O (7.05g, 20mmo1) is put into a reaction system, a mixed solution of 360mL of ethylene glycol ethyl ether and 120mL of purified water is added, the mixture is refluxed for 28 hours under the protection of nitrogen, then cooled to room temperature, precipitates are separated out, the precipitates are filtered by suction, and water, absolute ethyl alcohol and petroleum ether are used for flushing in sequenceWashing and drying to obtain the bridging ligand IV-153 of dark red powder, wherein the mass is 7.91g, and the yield is 48%.
(2) Then weighing the bridging ligand IV-153 (7.42g, 4.5mmol), adding anhydrous potassium carbonate (6.21g, 45mmol), adding 150ml ethylene glycol ethyl ether into the system, replacing nitrogen for three times, adding the formula III-153 (5.09g, 22.5mmol) under nitrogen, refluxing for 20 hours under nitrogen protection, cooling, filtering, washing with alcohol, and drying. Using dichloromethane as a solvent, performing chromatography by using a neutral alumina column, concentrating the filtrate, and precipitating a solid to obtain the organic iridium complex shown in the formula I-153, wherein the mass of the organic iridium complex is 2.65g, the yield is 29%, and the HPLC purity is more than 99.5%.
In addition, the mass spectrum of the organic iridium complex is calculated as 1013.49; the test value was 1013.72.
Elemental analysis (%): calculated value is C: 32.00; 43.11 is used as a reference material; 18.97 of Ir; n is 2.76; o is 3.16, and the test value is C is 32.01; f is 43.13; 18.98 parts of Ir; n is 2.74; o is 3.14.
As can be seen by comparing the calculated values with the test values, the measured values are substantially consistent with the theoretical values, thereby proving that the organic iridium complexes with the structural formula I-153 can be successfully synthesized by the complex examples.
Examples 7 to 16 of the complexes
Because the synthetic route and the principle of the preparation method of other organic iridium complexes with the structural general formula of formula I in the invention content are the same as those of the listed complex example 1, the corresponding organic iridium complexes can be obtained only by respectively replacing ligands with compounds corresponding to the corresponding ligand structures in the target product and correspondingly adjusting the material dosage according to the corresponding stoichiometric ratio, so that the method is not exhaustive, and a plurality of organic iridium complexes are selected as the complex examples 7-21 in the invention, and are specifically shown in the following table 1.
TABLE 1
Figure BDA0002669605910000341
Figure BDA0002669605910000351
The embodiment of the invention also provides a photoelectric device prepared by using the organic iridium complex provided by the embodiment, and particularly, the photoelectric device is an organic electroluminescent device, wherein the organic electroluminescent device comprises a first electrode, a second electrode and at least one organic layer arranged between the first electrode and the second electrode.
The organic layer may include at least one layer selected from a hole injection layer, a hole transport layer, a composite layer of hole injection and hole transport technical layers, an electron blocking layer, an emission layer, a hole blocking layer, an electron transport layer, an electron injection layer, an electron transport layer and a composite layer of electron injection technical layers, and at least one layer may or may not include the organic iridium complex.
Specifically, the light-emitting layer includes a host material and a dopant material; wherein, the host material can be 4, 4'-N, N' -biphenyl dicarbazole (CBP), but is not limited thereto; the doping material can be selected from the organic iridium complexes.
In practical applications, the method for manufacturing the organic electroluminescent device can refer to device example 1 below.
Device example 1
The device embodiment 1 provides an organic electroluminescent device, and a manufacturing method thereof includes the steps of:
(1) coating with a thickness of
Figure BDA0002669605910000352
The ITO glass substrate of (1) was cleaned in distilled water for 2 times, ultrasonically cleaned for 30 minutes, repeatedly cleaned with distilled water for 2 times, ultrasonically cleaned for 10 minutes, and after the cleaning with distilled water was completed, the substrate was dried after sequentially ultrasonically cleaned with solvents of isopropyl alcohol, acetone, and methanol (each time, 10 minutes), transferred to a plasma cleaning machine, cleaned for 5 minutes, and sent to an evaporation coater.
(2) Under vacuum conditions, the standard pressure was set at 1X 10-6The support, which takes ITO as the anode,first vapor-depositing thereon
Figure BDA0002669605910000353
Then sequentially evaporating
Figure BDA0002669605910000354
A mixture of the host substance 4, 4'-N, N' -Biphenyldicarbazole (CBP) and the above-mentioned organic iridium complex I-1 ((II))
Figure BDA0002669605910000355
Wherein the weight ratio of the 4, 4'-N, N' -biphenyl dicarbazole to the organic iridium complex I-1 is 95:5), and an electron transport layer
Figure BDA0002669605910000361
Electron injection layer
Figure BDA0002669605910000362
Cathode electrode
Figure BDA0002669605910000363
And the organic electroluminescent device can be prepared.
Wherein, CuPc, NPB, CBP, Alq3The structural formula of (A) is as follows:
Figure BDA0002669605910000364
device examples 2 to 21
An organic electroluminescent device was fabricated by referring to the fabrication method provided in device example 1 above, except that the organic iridium complex i-1 (dopant) in device example 1 above was replaced with the organic iridium complexes of formulae i-4, i-14, i-23, i-30, i-36, i-42, i-54, i-61, i-70, i-80, i-84, i-95, i-100, i-111, i-120, i-127, i-129, i-140, i-148, and i-153 above, respectively, to fabricate a corresponding organic electroluminescent device.
Comparative device example 1
Preparation method provided with reference to device example 1 aboveAn organic electroluminescent device was prepared, except that the organic iridium complex I-1 (dopant) in the above device example 1 was replaced with the existing iridium metal complex (btp)2Ir (acac), where (btp)2The structural formula of Ir (acac) is as follows:
Figure BDA0002669605910000371
experimental example:
the performance and the light emitting characteristics of the organic electroluminescent devices obtained in the device examples 1 to 21 and the device comparative example 1 were respectively tested under the same current conditions by using a KEITHLEY model 2400 source measuring unit and a CS-2000 spectroradiometer to evaluate the driving voltage, the current efficiency and the light emitting life of the organic electroluminescent device (T95), and the specific test results are shown in table 2.
TABLE 2
Figure BDA0002669605910000372
Figure BDA0002669605910000381
From Table 2 above, it can be seen that the ratio (btp) is higher than that provided in comparative device example 12The organic electroluminescent device prepared by using the organic iridium complex provided by the embodiment of the invention as the doping material can effectively reduce the driving voltage of a photoelectric device, and can remarkably improve the current efficiency and service life of the organic electroluminescent device.
In light of the foregoing description of the preferred embodiment of the present invention, many modifications and variations will be apparent to those skilled in the art without departing from the spirit and scope of the invention. The technical scope of the present invention is not limited to the content of the specification, and must be determined according to the scope of the claims.

Claims (10)

1. An organic iridium complex containing heteroatoms, which is characterized in that the structural general formula of the organic iridium complex is as shown in formula I:
Figure FDA0002669605900000011
in the formula, R1、R2Represents at least one or no substituent, R3、R4、R5Represents a single or no substituent; r1、R2The substituent position is any position of the ring on which each is positioned;
R1、R2、R3、R4、R5each independently is at least one of hydrogen, deuterium atom, halogen, cyano, nitro, hydroxyl, amino, sulfonic group, sulfonyl, phosphoryl, substituted or unsubstituted C1-C60 alkyl, substituted or unsubstituted C6-C60 aryl, substituted or unsubstituted C3-C60 cycloalkyl, substituted or unsubstituted C1-C60 alkoxy, substituted or unsubstituted C1-C60 alkylamino, substituted or unsubstituted C2-C60 alkylene, substituted or unsubstituted C2-C60 alkynyl, substituted or unsubstituted C2-C60 heterocyclic group and substituted or unsubstituted C10-C60 condensed ring group;
a is any one of C3-C10 naphthenic base and C3-C12 heterocyclic radical; b is any one of C3-C10 naphthenic base, C3-C12 heterocyclic radical and C6-C20 aryl; and the condition that the ring of A is isoquinoline and the ring of B is a benzene ring does not exist at the same time.
2. The heteroatom-containing organic iridium complex of claim 1 wherein R1、R2、R3、R4、R5Each independently is hydrogen, deuterium atom, halogen, cyano, substituted or unsubstituted C1-C20 alkyl, substituted or unsubstituted C3-C20 cycloalkyl, substituted or unsubstituted C2-C20 heterocyclic, substituted or unsubstituted C6-C20 aryl, substituted or unsubstituted C,At least one of substituted or unsubstituted C10-C20 condensed ring group.
3. The organic iridium complex containing hetero atoms according to claim 1, wherein R is3、R4、R5At least one of which is F.
4. The heteroatom-containing organic iridium complex of claim 1, wherein the chemical formula of the organic iridium complex is represented by formula I-1, formula I-2, formula I-3, formula I-4, formula I-5, formula I-6, formula I-7, formula I-8, formula I-9, formula I-10, formula I-11, formula I-12, formula I-13, formula I-14, formula I-15, formula I-16, formula I-17, formula I-18, formula I-19, formula I-20, formula I-21, formula I-22, formula I-23, formula I-24, formula I-25, formula I-26, formula I-27, formula I-28, formula I-29, formula I-30, Formula I-31, formula I-32, formula I-33, formula I-34, formula I-35, formula I-36, formula I-37, formula I-38, formula I-39, formula I-40, formula I-41, formula I-42, formula I-43, formula I-44, formula I-45, formula I-46, formula I-47, formula I-48, formula I-49, formula I-50, formula I-51, formula I-52, formula I-53, formula I-54, formula I-55, formula I-56, formula I-57, formula I-58, formula I-59, formula I-60, formula I-61, formula I-62, formula I-63, formula I-64, formula I-65, formula I-66, formula I-67, Formula I-68, formula I-69, formula I-70, formula I-71, formula I-72, formula I-73, formula I-74, formula I-75, formula I-76, formula I-77, formula I-78, formula I-79, formula I-80, formula I-81, formula I-82, formula I-83, formula I-84, formula I-85, formula I-86, formula I-87, formula I-88, formula I-89, formula I-90, formula I-91, formula I-92, formula I-93, formula I-94, formula I-95, formula I-96, formula I-97, formula I-98, formula I-99, formula I-100, formula I-101, formula I-102, formula I-103, formula I-104, Formula I-105, formula I-106, formula I-107, formula I-108, formula I-109, formula I-110, formula I-111, formula I-112, formula I-113, formula I-114, formula I-115, formula I-116, formula I-117, formula I-118, formula I-119, formula I-120, formula I-121, formula I-122, formula I-123, formula I-124, formula I-125, formula I-126, formula I-127, formula I-128, formula I-129, formula I-130, formula I-131, formula I-132, formula I-133, formula I-134, formula I-135, formula I-136, formula I-137, formula I-138, formula I-139, formula I-140, formula I-141, Any one of formulae I-142, formulae I-143, formulae I-144, formulae I-145, formulae I-146, formulae I-147, formulae I-148, formulae I-149, formulae I-150, formulae I-151, formulae I-152, formulae I-153, formulae I-154, formulae I-155, formulae I-156, formulae I-157, formulae I-158, formulae I-159, formulae I-160:
Figure FDA0002669605900000031
Figure FDA0002669605900000041
Figure FDA0002669605900000051
Figure FDA0002669605900000061
Figure FDA0002669605900000071
Figure FDA0002669605900000081
Figure FDA0002669605900000091
Figure FDA0002669605900000101
Figure FDA0002669605900000111
Figure FDA0002669605900000121
Figure FDA0002669605900000131
Figure FDA0002669605900000141
Figure FDA0002669605900000151
Figure FDA0002669605900000161
Figure FDA0002669605900000171
Figure FDA0002669605900000181
Figure FDA0002669605900000191
Figure FDA0002669605900000201
Figure FDA0002669605900000211
Figure FDA0002669605900000221
5. a method for preparing an organic iridium complex according to any one of claims 1 to 4, comprising the steps of:
taking a compound with a structural general formula of formula II and a compound with a structural general formula of formula III;
reacting a compound with a general formula II with iridium trichloride to obtain a compound with a general formula IV;
reacting a compound with a general formula IV and a compound with a general formula III to obtain the organic iridium complex;
6. the method for preparing an organic iridium complex according to claim 5, wherein in the step, the compound having the general structural formula II and iridium trichloride are reacted in a mixed solution of ethylene glycol ethyl ether and water.
7. The method according to claim 5, wherein the compound of formula IV is reacted with the compound of formula III in the presence of a base in ethylene glycol ether.
8. The method according to claim 7, wherein the base is anhydrous potassium carbonate.
9. An optoelectronic device comprising a first electrode, a second electrode and at least one organic layer disposed between said first electrode and said second electrode, wherein said organic layer comprises an organic iridium complex according to any one of claims 1 to 4.
10. The optoelectronic device according to claim 9, wherein the organic layer comprises a light-emitting layer; the light-emitting layer comprises a host material and a doping material; the doping material partially or entirely contains the organic iridium complex.
CN202010929227.XA 2020-09-07 2020-09-07 Organic iridium complex containing heteroatom, preparation method thereof and photoelectric device Pending CN112028944A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010929227.XA CN112028944A (en) 2020-09-07 2020-09-07 Organic iridium complex containing heteroatom, preparation method thereof and photoelectric device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010929227.XA CN112028944A (en) 2020-09-07 2020-09-07 Organic iridium complex containing heteroatom, preparation method thereof and photoelectric device

Publications (1)

Publication Number Publication Date
CN112028944A true CN112028944A (en) 2020-12-04

Family

ID=73585058

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010929227.XA Pending CN112028944A (en) 2020-09-07 2020-09-07 Organic iridium complex containing heteroatom, preparation method thereof and photoelectric device

Country Status (1)

Country Link
CN (1) CN112028944A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114736244A (en) * 2022-05-05 2022-07-12 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110330530A (en) * 2019-07-10 2019-10-15 吉林奥来德光电材料股份有限公司 Iridium metal complex and preparation method thereof and organic electroluminescence device containing the compound
CN110684052A (en) * 2019-11-15 2020-01-14 吉林奥来德光电材料股份有限公司 Organic metal iridium complex, preparation method thereof and electroluminescent device
CN110804436A (en) * 2019-11-15 2020-02-18 吉林奥来德光电材料股份有限公司 Iridium-matched electroluminescent material, preparation method thereof and electroluminescent device
CN110845543A (en) * 2019-11-26 2020-02-28 吉林奥来德光电材料股份有限公司 Organic iridium metal complex, preparation method thereof and organic electroluminescent device
CN110862419A (en) * 2019-12-02 2020-03-06 吉林奥来德光电材料股份有限公司 Metal iridium complex, preparation method thereof, luminescent material, organic electroluminescent device, display screen and solar cell
CN111377976A (en) * 2020-03-09 2020-07-07 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material and preparation method and application thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110330530A (en) * 2019-07-10 2019-10-15 吉林奥来德光电材料股份有限公司 Iridium metal complex and preparation method thereof and organic electroluminescence device containing the compound
CN110684052A (en) * 2019-11-15 2020-01-14 吉林奥来德光电材料股份有限公司 Organic metal iridium complex, preparation method thereof and electroluminescent device
CN110804436A (en) * 2019-11-15 2020-02-18 吉林奥来德光电材料股份有限公司 Iridium-matched electroluminescent material, preparation method thereof and electroluminescent device
CN110845543A (en) * 2019-11-26 2020-02-28 吉林奥来德光电材料股份有限公司 Organic iridium metal complex, preparation method thereof and organic electroluminescent device
CN110862419A (en) * 2019-12-02 2020-03-06 吉林奥来德光电材料股份有限公司 Metal iridium complex, preparation method thereof, luminescent material, organic electroluminescent device, display screen and solar cell
CN111377976A (en) * 2020-03-09 2020-07-07 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STN-REGISTRY: "CAS RN:722538-57-0", 《STN-REGISTRY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114736244A (en) * 2022-05-05 2022-07-12 吉林奥来德光电材料股份有限公司 Organic phosphorus luminescent material and preparation method and application thereof
CN114736244B (en) * 2022-05-05 2024-02-23 吉林奥来德光电材料股份有限公司 Organic iridium luminescent material and preparation method and application thereof

Similar Documents

Publication Publication Date Title
WO2021018270A1 (en) Host compound and organic electroluminescent device using same
JP2019165234A (en) Light-emitting device
CN112375071B (en) Organic light-emitting compound and preparation method and application thereof
CN113105341A (en) Nitrogen-containing phenanthrene compound, preparation method thereof, functional material and organic electroluminescent device
CN108997438B (en) Red phosphorescent compound and organic light emitting diode device using the same
CN111116628A (en) Organic compound and organic electroluminescent device using same
CN111995531A (en) Organic electroluminescent compound containing adamantane structure and preparation method and application thereof
CN111825725A (en) Iridium metal complex luminescent material and preparation and application thereof
CN109988193B (en) Green phosphorescent compound and organic electroluminescent device using the same
CN111808147B (en) Organic phosphorescent material, preparation method thereof and electroluminescent device
CN112028944A (en) Organic iridium complex containing heteroatom, preparation method thereof and photoelectric device
CN112047872B (en) Organic electroluminescent fluorene compound and preparation method and application thereof
CN113683515A (en) Nitrogen-containing phenanthrene compound, preparation method thereof, functional material and organic electroluminescent device
CN112430226A (en) Arylamine naphthofuran compound and preparation method and application thereof
CN110684053B (en) Complex and preparation method thereof, phosphorescent material, organic electroluminescent device, display screen and solar cell
CN111675687A (en) Organic electroluminescent compound and preparation method and application thereof
CN109810146B (en) Green phosphorescent compound and organic electroluminescent device using the same
CN110724168A (en) Red phosphorescent compound and organic electroluminescent device using the same
CN110872301A (en) Phosphorescent compound and organic light emitting diode device using the same
CN113620951B (en) Phosphorescent compound, preparation method thereof and organic electroluminescent device
CN111116675A (en) Organic phosphorus luminescent material and preparation method and application thereof
CN112300175B (en) Multi-heterocyclic compound and application thereof
KR20150015252A (en) Compound, organic optoelectric device and display device
CN110746464A (en) Red phosphorescent compound and organic electroluminescent device using the same
CN110872328A (en) Red phosphorescent compound and organic electroluminescent device using the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20201204